Generative AI In Life Sciences Market Size, Share, and Trends 2026 to 2035

Generative AI in Life Sciences Market (By Technology: Novel molecule generation, Protein sequence design, Synthetic gene design, Single-cell RNA sequencing, Data augmentation for model training; By Application: Drug Discovery, Biotechnology, Medical Diagnosis, Clinical Trials, Precision and Personalized Medicine, Patient Monitoring) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 26 Dec 2025  |  Report Code : 3139  |  Category : ICT   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Generative AI in Life Sciences Market 

5.1. COVID-19 Landscape: Generative AI in Life Sciences Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Generative AI in Life Sciences Market, By Technology

8.1. Generative AI in Life Sciences Market, by Technology

8.1.1. Novel molecule generation

8.1.1.1. Market Revenue and Forecast

8.1.2. Protein sequence design

8.1.2.1. Market Revenue and Forecast

8.1.3. Synthetic gene design

8.1.3.1. Market Revenue and Forecast

8.1.4. Single-cell RNA sequencing

8.1.4.1. Market Revenue and Forecast

8.1.5. Data augmentation for model training

8.1.5.1. Market Revenue and Forecast

Chapter 9. Global Generative AI in Life Sciences Market, By Application

9.1. Generative AI in Life Sciences Market, by Application

9.1.1. Drug Discovery

9.1.1.1. Market Revenue and Forecast

9.1.2. Biotechnology

9.1.2.1. Market Revenue and Forecast

9.1.3. Medical Diagnosis

9.1.3.1. Market Revenue and Forecast

9.1.4. Clinical Trials

9.1.4.1. Market Revenue and Forecast

9.1.5. Precision and Personalized Medicine

9.1.5.1. Market Revenue and Forecast

9.1.6. Patient Monitoring

9.1.6.1. Market Revenue and Forecast

Chapter 10. Global Generative AI in Life Sciences Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Technology

10.1.2. Market Revenue and Forecast, by Application

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Technology

10.1.3.2. Market Revenue and Forecast, by Application

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Technology

10.1.4.2. Market Revenue and Forecast, by Application

10.2. Europe

10.2.1. Market Revenue and Forecast, by Technology

10.2.2. Market Revenue and Forecast, by Application

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Technology

10.2.3.2. Market Revenue and Forecast, by Application

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Technology

10.2.4.2. Market Revenue and Forecast, by Application

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Technology

10.2.5.2. Market Revenue and Forecast, by Application

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Technology

10.2.6.2. Market Revenue and Forecast, by Application

10.3. APAC

10.3.1. Market Revenue and Forecast, by Technology

10.3.2. Market Revenue and Forecast, by Application

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Technology

10.3.3.2. Market Revenue and Forecast, by Application

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Technology

10.3.4.2. Market Revenue and Forecast, by Application

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Technology

10.3.5.2. Market Revenue and Forecast, by Application

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Technology

10.3.6.2. Market Revenue and Forecast, by Application

10.4. MEA

10.4.1. Market Revenue and Forecast, by Technology

10.4.2. Market Revenue and Forecast, by Application

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Technology

10.4.3.2. Market Revenue and Forecast, by Application

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Technology

10.4.4.2. Market Revenue and Forecast, by Application

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Technology

10.4.5.2. Market Revenue and Forecast, by Application

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Technology

10.4.6.2. Market Revenue and Forecast, by Application

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Technology

10.5.2. Market Revenue and Forecast, by Application

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Technology

10.5.3.2. Market Revenue and Forecast, by Application

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Technology

10.5.4.2. Market Revenue and Forecast, by Application

Chapter 11. Company Profiles

11.1. IBM Corporation

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. AiCure LLC

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. MosaicML

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. NVIDIA

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Insilico Medicine Inc.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Writer

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. HealthArk

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The global generative AI in life sciences market size surpassed USD 282.31 million in 2025 and it is expected to increase USD 1779.32 million by 2035.

Answer : The global generative AI in life sciences market will register growth rate of 20.21% between 2026 and 2035.

Answer : The major players operating in the generative AI in life sciences market are IBM Corporation, AiCure LLC, MosaicML, NVIDIA, Insilico Medicine Inc., Writer, HealthArk, and Others.

Answer : The driving factors of the generative AI in life sciences market are the emphasis on drug discovery and development and demand for precision medicine.

Answer : North America region will lead the global generative AI in life sciences market during the forecast period 2026 to 2035.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client